nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A nomogram to predict pathologic complete response (pCR) and the value of tumor-infiltrating lymphocytes (TILs) for prediction of response to neoadjuvant chemotherapy (NAC) in breast cancer patients
|
Hwang, Hye Won |
|
2018 |
173 |
2 |
p. 255-266 |
artikel |
2 |
A randomized trial of interpersonal psychotherapy, problem solving therapy, and supportive therapy for major depressive disorder in women with breast cancer
|
Blanco, Carlos |
|
2018 |
173 |
2 |
p. 353-364 |
artikel |
3 |
Better pathological tumor characteristics might occur in recurrent metastatic breast cancer patients after 10-year metastatic free interval
|
Altundag, Kadri |
|
2018 |
173 |
2 |
p. 483 |
artikel |
4 |
Body composition is associated with risk of toxicity-induced modifications of treatment in women with stage I–IIIB breast cancer receiving chemotherapy
|
van den Berg, Maaike M. G. A. |
|
2018 |
173 |
2 |
p. 475-481 |
artikel |
5 |
Breast conservation versus mastectomy in patients with T3 breast cancers (> 5 cm): an analysis of 37,268 patients from the National Cancer Database
|
Mazor, Anna M. |
|
2018 |
173 |
2 |
p. 301-311 |
artikel |
6 |
Correction to: Efficacy and safety of fulvestrant in postmenopausal patients with hormone receptor-positive advanced breast cancer: a systematic literature review and meta-analysis
|
Wang, Jiayu |
|
2018 |
173 |
2 |
p. 487 |
artikel |
7 |
Discrepancy in risk assessment of hormone receptor positive early-stage breast cancer patients using breast cancer index and recurrence score
|
Jerevall, Piiha-Lotta |
|
2018 |
173 |
2 |
p. 375-383 |
artikel |
8 |
Efficacy of neoadjuvant pertuzumab in addition to chemotherapy and trastuzumab in routine clinical treatment of patients with primary breast cancer: a multicentric analysis
|
Fasching, Peter A. |
|
2018 |
173 |
2 |
p. 319-328 |
artikel |
9 |
Extranodular extension in sentinel lymph node-positive breast cancer might predict further initiation of completion axillary lymph node dissection
|
Altundag, Kadri |
|
2018 |
173 |
2 |
p. 485 |
artikel |
10 |
High patient satisfaction with a simplified BRCA1/2 testing procedure: long-term results of a prospective study
|
Nilsson, Martin P. |
|
2018 |
173 |
2 |
p. 313-318 |
artikel |
11 |
Impact of Topoisomerase IIα, PTEN, ABCC1/MRP1, and KI67 on triple-negative breast cancer patients treated with neoadjuvant chemotherapy
|
Guestini, Fouzia |
|
2018 |
173 |
2 |
p. 275-288 |
artikel |
12 |
Improving the competency of medical students in clinical breast examination through a standardized simulation and multimedia-based curriculum
|
Angarita, Fernando A. |
|
2018 |
173 |
2 |
p. 439-445 |
artikel |
13 |
Machine learning for diagnostic ultrasound of triple-negative breast cancer
|
Wu, Tong |
|
2018 |
173 |
2 |
p. 365-373 |
artikel |
14 |
Metronomic capecitabine combined with aromatase inhibitors for new chemoendocrine treatment of advanced breast cancer: a phase II clinical trial
|
Li, Jian-wei |
|
2018 |
173 |
2 |
p. 407-415 |
artikel |
15 |
Mucin 2 (MUC2) modulates the aggressiveness of breast cancer
|
Astashchanka, Anna |
|
2018 |
173 |
2 |
p. 289-299 |
artikel |
16 |
Multivariate machine learning models for prediction of pathologic response to neoadjuvant therapy in breast cancer using MRI features: a study using an independent validation set
|
Cain, Elizabeth Hope |
|
2018 |
173 |
2 |
p. 455-463 |
artikel |
17 |
One year versus a shorter duration of adjuvant trastuzumab for HER2-positive early breast cancer: a systematic review and meta-analysis
|
Inno, Alessandro |
|
2018 |
173 |
2 |
p. 247-254 |
artikel |
18 |
Oral etoposide in heavily pre-treated metastatic breast cancer: results from the ESME cohort and comparison with other chemotherapy regimens
|
Cabel, Luc |
|
2018 |
173 |
2 |
p. 397-406 |
artikel |
19 |
Predictors of time to death after distant recurrence in breast cancer patients
|
Sopik, Victoria |
|
2018 |
173 |
2 |
p. 465-474 |
artikel |
20 |
Prevalence and oncologic outcomes of BRCA 1/2 mutations in unselected triple-negative breast cancer patients in Korea
|
Ryu, Jai Min |
|
2018 |
173 |
2 |
p. 385-395 |
artikel |
21 |
Prognosis in different subtypes of metaplastic breast cancer: a population-based analysis
|
He, Xuexin |
|
2018 |
173 |
2 |
p. 329-341 |
artikel |
22 |
Sentinel lymph node biopsy without axillary lymphadenectomy after neoadjuvant chemotherapy is accurate and safe for selected patients: the GANEA 2 study
|
Classe, Jean-Marc |
|
2018 |
173 |
2 |
p. 343-352 |
artikel |
23 |
Surgical trends in breast cancer: a rise in novel operative treatment options over a 12 year analysis
|
Jonczyk, Michael M. |
|
2018 |
173 |
2 |
p. 267-274 |
artikel |
24 |
The impact of gene expression profile testing on confidence in chemotherapy decisions and prognostic expectations
|
Panattoni, Laura |
|
2018 |
173 |
2 |
p. 417-427 |
artikel |
25 |
The influence of reconstruction choice and inclusion of radiation therapy on functional shoulder biomechanics in women undergoing mastectomy for breast cancer
|
Leonardis, Joshua M. |
|
2018 |
173 |
2 |
p. 447-453 |
artikel |
26 |
Which patients with sentinel node-positive breast cancer after breast conservation still receive completion axillary lymph node dissection in routine clinical practice?
|
Hennigs, André |
|
2018 |
173 |
2 |
p. 429-438 |
artikel |